Diagnosis of Sacroiliac (SI)
Joint Dysfunction

Sacroiliac (SI) Joint dysfunction requires appropriate interpretation of a patient’s history, clinical exam results, and imaging studies. Often hip pathology and lumbar pathology coexists with Sacroiliac (SI) Joint pathology. During physical examination, patients with Sacroiliac (SI) Joint dysfunction exhibit any/all of the following symptoms:
  • Low back pain
  • Palpable tenderness of the posterior pelvic Sacroiliac (SI) region
  • Provocative maneuvers to the hip (i.e. Faber test) and the absence of neurologic deficit
  • Joint asymmetry may be seen on CT and MRI.

When the Sacroiliac (SI) Joint is suspected as the source of the patient’s low back pain, confirmation is provided by CT or fluoroscopic guided injection. This injection is the diagnostic “Litmus test.” If Lidocaine is injected into the joint and symptoms temporarily resolve, this is confirmation of the Sacroiliac (SI) Joint as the source of the patient’s low back pain.

Once confirmed, treatment for Sacroiliac (SI) Joint dysfunction has heretofore been limited to NSAID prescriptions, physical therapy, chiropractic/osteopathic manipulations, muscle rehabilitation, and steroid injections. In some cases, these yield fair short-term relief, but symptom recurrence is the rule with Sacroiliac (SI) Joint dysfunction. Until now, a permanent solution has not been an option for the patient.

An Advanced Approach to Surgical Management of SI Joint Dysfunction
Up to 25% of all low back pain is SI Joint in origin but the diagnosis of SI Joint disease is frequently overlooked. (Cohen, et al.)
It is common to link low back pain with protruding disc even when neurological signs are absent. (Weksler, et al.)
It is common for pain from SI Joint dysfunction to mimic discogenic or radicular low back pain. (Weksler, et al.)
Many patients go on to receive lumbar fusion instead of SI Joint fusion so SI Joint disease should be strongly considered in differential diagnosis of low back pain. (Weksler, et al.)
Now there is an approach to surgical management of SI Joint dysfunction thats easier and less invasive than traditional open surgery.
The iFuse Implant System consists of porous plasma spray coated implants, surgically inserted across the SI Joint to create fixation leading to fusionfrom the inside.
The iFuse creates a biomechanically rigorous fixation/fusion system, designed to support reliable fixation/fusion and acute weight bearing capacity.
With the iFuse Implant System, there is no need for BMP in conjunction with autologous bone graft or additional pedicle screws, rods or hollow modular anchorage screws or cannulated compression screws or threaded cages within the joint or fracture fixation screws.
iFuse benefits:
The iFuse Implant System is designed to be the sacroiliac joint fusion/fixation method of choice for spine surgeons.
iFuse is a minimally invasive surgical solution to replace open surgical SI Joint fusion.
With iFuse there's minimal incision size, minimal soft tissue stripping, minimal tendon irritation and reduced risk of infection.
iFuse is a simplified minimally invasive surgical procedure.
Just drill, broach, insert Implants and close.
iFuse has a simple technique which reduces OR time to less than 1 hour.
iFuse has 3X shear and 7X bending strength compared with screws.
iFuse has improved patient perception of stability post-implant.
The incidence of SI joint degeneration in patients was 75% at 5 years post-fusion, which was significantly higher than in the non-fusion group, 38.2%. (Ha, et al.)
Among patients with one-segment fusion, 91% developed SI joint degeneration. (Ha, et al.)
Regardless of whether the fusion includes the sacrum, the SI joint is influenced by increased mechanical stress arising from lumbar/lumbosacral fusion. (Ha, et al.)
Posterolateral lumbar/lumbosacral fusion can be a cause of SIJ degeneration. (Ha, et al.)